Welcome to our dedicated page for Mannatech SEC filings (Ticker: MTEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Mannatech, Incorporated (NASDAQ: MTEX) SEC filings page on Stock Titan provides streamlined access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. Mannatech is a global health and wellness company that develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products through a network of independent associates and preferred customers in multiple international markets.
Here, users can review Mannatech’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which include detailed discussions of net sales by region (Americas, Asia/Pacific, EMEA), gross profit, commission and incentive expenses, selling and administrative costs, and income or loss from operations. These filings also describe the company’s use of non-GAAP Constant dollar measures that adjust for foreign currency translation, as well as risk factors related to competition, regulatory changes, economic conditions, and trade policies.
Stock Titan surfaces current reports on Form 8-K that Mannatech files to announce material events, such as quarterly financial results, leadership changes, and board or governance updates. These 8-K filings often attach the full earnings press releases as exhibits, providing additional narrative and data tables.
With real-time updates from EDGAR and AI-powered summaries, this page helps users quickly interpret lengthy Mannatech filings by highlighting key metrics, changes in financial condition, and notable disclosures. Investors can also use the filings feed to monitor items such as debt arrangements, notes payable, and other balance sheet developments that appear in Mannatech’s periodic reports and related documents.
Mannatech, Inc. filed a Current Report on Form 8-K dated August 12, 2025, stating that it issued a press release on May 13, 2025 announcing financial and operating results for the quarter ended June 30, 2025.
The filing furnishes that press release as Exhibit 99.1, titled "Mannatech Reports Financial Results for Second Quarter 2025". The 8-K lists the company's Nasdaq trading symbol MTEX and is signed by Chief Executive Officer Landen Fredrick. The 8-K text itself does not include numerical financial results; investors should review Exhibit 99.1 for the full figures.
Mannatech, Inc. reported consolidated net sales of $25.7 million for the three months ended June 30, 2025, down 7.4% from $27.7 million a year earlier; six-month sales were $52.2 million, down 8.6% from $57.1 million. Management attributes the revenue decline principally to weakened economic conditions in certain regions.
The company recorded a net loss of $4.3 million for Q2 2025 (loss per diluted share $2.27) versus a $0.6 million loss in Q2 2024; for the six months it reported a $5.8 million loss compared with six‑month net income of $0.6 million in 2024. A $2.7 million net foreign currency translation loss materially affected results. Cash and cash equivalents totaled $5.525 million (cash plus restricted cash $6.685 million) at June 30, 2025, down from $12.515 million at the period start. Inventories increased to $12.6 million; total assets were $32.8 million and shareholders' equity was $5.964 million at period end.